vTv Therapeutics Inc (NASDAQ: VTVT) stock enjoyed a major increase of 11.2% on 11/15/24. The shares closed at $17.40. However, this advance was accompanied by below average trading volume at 77% of normal. The stock has been weak relative to the market over the last nine months but has risen 27.9% during the last week.
Current PriceTarget Research Rating
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment